Mostrando 2 resultados de: 2
A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: A new strategy for heart failure diagnostics and therapeutics
ArticleAbstract: Aims Ongoing inflammation and endothelial dysfunction occurs within the local microenvironment of hePalabras claves:cardiomyopathy, Heart Failure, Nanoconstructs, Nanomedicine, Nanoparticles, nanotechnologyAutores:Amione-Guerra J., Andrea M. Cordero-Reyes, Blanco E., Cara F.E., Cruz-Solbes A.S., Ferrari M., Flores-Arredondo J.H., García-Rivas G., Guerrero-Beltrán C.E.n., Kirui D.K., Paez-Mayorga J., Ruiz-Esparza G.U., Segura-Ibarra V., Serda R.E., Torre-Amione G., Yokoi K., Youker K.A.Fuentes:scopusHigh proportion of patients with end-stage heart failure regardless of aetiology demonstrates anti-cardiac antibody deposition in failing myocardium: Humoral activation, a potential contributor of disease progression
ArticleAbstract: Aims Various reports have raised the possibility of humoral immune responses as contributors for thePalabras claves:Antibodies, ATP synthase, autoimmunity, Heart Failure, myocardiumAutores:Andrea M. Cordero-Reyes, Assad-Kottner C., Barrios R., Bhimaraj A., Estep J.D., Fernandez-Sada E., Flores-Arredondo J.H., Torre-Amione G., Trevino A.R., Youker K.A.Fuentes:scopus